Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Vanda Pharmaceuticals
VNDA
$306M
| $824K | ﹤0.01% |
125,065
+24,771
| +25% | +$159K |
|
|
XRN
2352
Chiron Real Estate Inc
XRN
$464M
| $823K | ﹤0.01% |
18,019
-1,437
| -7% | -$64.9K |
|
2353
Wabash National
WNC
$518M
| $822K | ﹤0.01% |
32,054
+7,312
| +30% | +$180K |
|
2354
FS Bancorp
FSBW
$323M
| $821K | ﹤0.01% |
27,306
-6,955
| -20% | -$204K |
|
2355
Bar Harbor Bankshares
BHB
$679M
| $820K | ﹤0.01% |
33,299
-1,795
| -5% | -$44.3K |
|
|
NOAH
2356
Noah Holdings
NOAH
$568M
| $820K | ﹤0.01% |
58,272
-6,510
| -10% | -$102K |
|
2357
Sylvamo
SLVM
$1.54B
| $820K | ﹤0.01% |
20,276
+1,626
| +9% | +$70.2K |
|
2358
Modine Manufacturing
MOD
$10.3B
| $820K | ﹤0.01% |
24,821
-8,658
| -26% | -$216K |
|
|
BBBY
2359
Bed Bath & Beyond
BBBY
$440M
| $819K | ﹤0.01% |
27,672
-31,197
| -53% | -$576K |
|
2360
Hawkins
HWKN
$2.82B
| $817K | ﹤0.01% |
17,138
-269
| -2% | -$12.1K |
|
2361
Kforce
KFRC
$1.05B
| $817K | ﹤0.01% |
13,036
-5,615
| -30% | -$338K |
|
2362
Energy Fuels
UUUU
$3.11B
| $816K | ﹤0.01% |
130,844
+3,617
| +3% | +$21.2K |
|
2363
Tompkins Financial
TMP
$1.45B
| $815K | ﹤0.01% |
14,627
+4,241
| +41% | +$244K |
|
2364
Takeda Pharmaceutical
TAK
$53.4B
| $814K | ﹤0.01% |
51,836
-1,638,505
| -97% | -$26.8M |
|
2365
International Seaways
INSW
$4.49B
| $814K | ﹤0.01% |
21,280
-3,534
| -14% | -$135K |
|
|
AVDL
2366
DELISTED
Avadel Pharmaceuticals
AVDL
| $813K | ﹤0.01% |
+49,335
| New | +$641K |
|
2367
Pricesmart
PSMT
$5.76B
| $813K | ﹤0.01% |
10,971
-5,427
| -33% | -$400K |
|
|
SLCA
2368
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $812K | ﹤0.01% |
66,974
-8,930
| -12% | -$110K |
|
|
YI
2369
111 Inc
YI
$32.5M
| $811K | ﹤0.01% |
32,980
| – | – |
|
|
GRIN
2370
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
| $811K | ﹤0.01% |
95,669
| – | – |
|
|
SQSP
2371
DELISTED
Squarespace, Inc.
SQSP
| $804K | ﹤0.01% |
25,504
-3,403
| -12% | -$103K |
|
2372
VanEck Junior Gold Miners ETF
GDXJ
$7.87B
| $804K | ﹤0.01% |
22,556
-59,464
| -72% | -$2.31M |
|
|
AVNS
2373
DELISTED
Avanos Medical
AVNS
| $802K | ﹤0.01% |
31,396
-4,516
| -13% | -$119K |
|
2374
ProShares UltraPro QQQ
TQQQ
$37B
| $802K | ﹤0.01% |
39,134
-23,530
| -38% | -$377K |
|
|
UNIT
2375
Uniti Group
UNIT
$2.35B
| $800K | ﹤0.01% |
173,225
+874
| +0.5% | +$3.29K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.